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Abstract
Background: Bovine herpesvirus type-1 (BHV-1) is an important pathogen of cattle that presents with a
variety of clinical signs, including the upper respiratory tract infection infectious bovine rhinotracheitis
(IBR). A seroepidemiological study of BHV-1 antibodies was conducted in England from 2002 – 2004:
29,782 blood samples were taken from 15,736 cattle from 114 herds which were visited on up to three
occasions. Antibody concentration was measured using a commercial ELISA. Farm management
information was collected using an interview questionnaire, and herd size and cattle movements were
obtained from the cattle tuberculosis testing database and the British Cattle Movement Service.
Hierarchical statistical models were used to investigate associations between cattle and herd variables and
the continuous outcome percentage positive (PP) values from the ELISA test in unvaccinated herds.
Results: There were 7 vaccinated herds, all with at least one seropositive bovine. In unvaccinated herds
83.2% had at least one BHV-1 seropositive bovine, and the mean cattle and herd BHV-1 seroprevalence
were 42.5% and 43.1% respectively. There were positive associations between PP value, age, herd size,
presence of dairy cattle. Adult cattle in herds with grower cattle had lower PP values than those in herds
without grower cattle. Purchased cattle had significantly lower PP values than homebred cattle, whereas
cattle in herds that were totally restocked after the foot-and-mouth epidemic in 2001 had significantly
higher PP values than those in continuously stocked herds. Samples taken in spring and summer had
significantly lower PP values than those taken in winter, whereas those taken in autumn had significantly
higher PP values than those taken in winter. The risks estimated from a logistic regression model with a
binary outcome (seropositive yes/no) were similar.
Conclusion: The prevalence of BHV-1 seropositivity in cattle and herds has increased since the 1970s.
Although the study population prevalence of BHV-1 was temporally stable during study period, the
associations between serological status and cattle age, herd size, herd type, presence of young stock and
restocked versus continuously stocked herds indicate that there is heterogeneity between herds and so
potential for further spread of BHV-1 within and between herds.
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Background
Bovine herpesvirus type-1 (BHV-1) is a member of the
family Herpesviridae, subfamily Alphaherpesvirinae. It is an
important pathogen of cattle worldwide [1]. Infection
with BHV-1 causes a variety of clinical diseases including
infectious bovine rhinotracheitis (IBR) (BHV-1 subtypes 1
and 2a), infectious pustular vulvovaginitis, infectious pus-
tular balanoposthitis (BHV-1 subtype 2b) and encephali-
tis (BHV-1 subtype 3) [2]. Conventional serological assays
cannot distinguish between antigenic serotypes of BHV-1.
BHV-1 generally infects cattle greater than 6 months of age
once maternal immunity has waned [3]. Clinical signs
associated with infection include nasal discharge, con-
junctivitis, fever, inappetance, milk drop, abortion and,
sometimes, death, although sub-clinical infection is pos-
sible [4,5]. The virus is shed in secretions from the eyes,
nose and reproductive organs. After initial infection and
disease, cattle become carriers of the virus which becomes
latent in the trigeminal or sacral ganglia. Reactivation of
the virus may occur when cattle are stressed [4] and virus
can then be transmitted to susceptible cattle. Infection can
occur indirectly through contaminated material and wind
borne particles [2].
BHV-1 has been in Great Britain (GB) since the 1960s [6].
IBR was first confirmed in GB in 1961 [7,8], but was not
considered clinically important in GB until an outbreak of
disease in Scotland in the late 1970s caused by a virulent
strain of BHV-1 (subtype 1) [9-11]. In England and Wales,
the overall prevalence of BHV-1 seropositive cattle was
2.1% in 1963 [6], rising to 15.1% of dairy and 16.8% of
suckler cattle over 2 yrs of age in Norfolk in 1991 [12], and
by 1992 BHV-1 antibodies were detected in 34% of cattle
herds in the UK [13].
The reported risk factors for the presence of BHV-1 anti-
bodies in cattle in the Netherlands included a large herd
size, dairy herds with beef/veal cattle, a high density of
herds in the municipality [14], purchasing cattle, cattle
participating in shows, professional visitors not using
farm protective clothing and herds situated close to other
BHV-1 positive herds [15]. In Belgium, seropositivity was
associated with increasing cattle age and herd size and
purchased cattle had a higher probability of being infected
than homebred cattle [16,17].
This paper presents the largest longitudinal study of BHV-
1 seropositivity in cattle in the UK, and its association
with cattle age, birthplace, herd type and size.
Methods
Source of data
The data used in this paper came from 114 dairy and/or
suckler herds in south west England. Farms were visited
between 2002 and 2006 and were located within the Ran-
domised Badger Culling Trial (RBCT) [18]. In addition,
the study included some farms that had been depopulated
in 2001 as a result of the foot-and-mouth disease (FMD)
epidemic [19] and subsequently repopulated. All the
farmers agreed to participate and allow their breeding cat-
tle to be sampled.
Samples of blood (up to 10 ml) were collected under
Home Office licence from all accessible cattle over 2 years
of age at three routine visits, at approximately one year
intervals. A subset of herds (n = 15) had a whole herd test,
i.e. blood samples were collected from cattle of all ages,
prompted by the presence of an animal persistently
infected (PI) with bovine viral diarrhoea virus (BVDV).
Four herds had a whole herd test instead of a routine third
visit; otherwise whole herd tests were additional to rou-
tine tests.
All blood samples were centrifuged at the University of
Warwick at 3220 g for 15 minutes, and serum was
removed and frozen at -20°C.
Farmers completed an interview questionnaire between
17th June 2003 and 18th February 2004 to obtain informa-
tion on clinical signs of infectious bovine rhinotracheitis
(IBR) disease and use of a BHV-1 vaccine. Four out of 114
farmers did not complete the questionnaire.
At each visit, the unique identity of cattle was recorded
from their ear tag and linked to the relevant blood sample.
When appropriate, freeze brand numbers were also
recorded. The ear tag was matched to the individual cattle
data on the British Cattle Movement Service (BCMS) to
obtain/confirm the following: the date of birth, whether
the animal was homebred or purchased, breed and sex.
More than 99% of cattle were matched within the BCMS
dataset. The main reason that cattle were not matched was
because they were born before 2001, when it was not
compulsory to record cattle birth dates. Herd size was esti-
mated from the cattle tuberculosis testing data (VetNet
database), and validated during farm visits.
All data were entered into a relational database (Post-
greSQL, PostgreSQL Global Development Group) using
Microsoft Access (Microsoft Corp. US) as a front end. All
data were screened for errors. When data mismatches were
detected, data were re-checked to determine the source of
the mismatch and where possible this was corrected.
Serological test and interpretation
The presence of BHV-1 specific antibodies (IgG1) was
detected using the SVANOVIR® IBR-Ab (Svanova Biotech
AB, Uppsala Sweden) indirect enzyme-linked immuno-
sorbent assay (ELISA). All testing was completed accord-BMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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ing to the kit instructions. Internal controls were included
on each plate to control for batch to batch variation. All
samples were run in duplicate, and all testing was com-
pleted at the University of Warwick. Positive samples were
re-tested when the duplicates were more than 0.25 optical
densities (OD) units apart or when the OD of the positive
controls was more than 0.2 OD units apart. The sensitivity
and specificity of the serological kit to the serum neutrali-
sation test have been reported as 97.4% and 92.4%
respectively [20]. BHV-1 antibody concentration was cal-
culated as the percentage of the positive control serum
(PP) using the following calculation:
The PP values ranged from -1.01 to 2.81. A sample was
defined as positive when the OD > cut-off and negative
when the OD < cut-off. The cut offs were:
Cut-off = 0.2 when ODNegative control × 2.5 < 0.2
Cut-off = ODNegative control × 2.5 when ODNegative control × 
2.5 ≥ 0.2
Vaccination
It was not possible to differentiate antibodies stimulated
through vaccination from those from natural infection
and so the 7 vaccinated herds were excluded from the
analysis.
Datasets
The full serological dataset consisted of 29,782 ELISA
results. Date of birth and identification of cattle were not
available for 1,838 and 344 observations respectively. For
the purpose of this study, two datasets (A and B) were
used. Dataset A included all serological results for all cattle
from herds that were not vaccinated against BHV-1 for all
visits (26,918 samples, 14,243 cattle, 107 herds). Dataset
B was a subset of Dataset A and included all serological
results from cattle >2 years of age from the three routine
visits and 4 whole herd visits (24,182 samples, 12,764 cat-
tle, 107 herds).
Outcome variables
A herd was defined as BHV-1 seropositive when at least
one cow in the herd was above the cut off for BHV-1 on at
least one occasion.
Cattle were defined as BHV-1 seropositive when above the
cut off for BHV-1 at least once.
The herd BHV-1 seroprevalence was calculated at each
visit as the number of seropositive cattle in the herd
divided by the total number of cattle tested.
Seroconversion was defined in a herd when at least one
cow changed from being seronegative to seropositive
between two visits.
Two outcomes were modelled to investigate associations
between BHV-1 seropositivity and herd and cow variables.
These were the continuous outcome PP, and a binary
(positive/negative) outcome (seropositive yes/no).
The explanatory variables
The variables listed in Table 1 were tested as fixed effects.
The variables triplet code (i.e. the form of badger control
in the RBCT), herd restocking status after the 2001 FMD
epidemic and farm geographical location were forced into
the models because they formed part of the study design.
Statistical analysis
Associations between the outcomes and herd and animal
factors were initially screened using Mann-Whitney and
chi-squared tests. Variables with a significance value of
<0.20 in the univariate analysis were tested in two multi-
level models: one with a continuous outcome of PP value
and one with a binary outcome of seropositive yes/no.





Table 1: The explanatory variables in the repeated measures multi-level model (Tables 3 and 4).
Explanatory variable Variable defined
Triplet Code Treatment in the Random Badger Culling Trial (RBCT)
Restocked Herd was depopulated due to the foot-and-mouth (FMD) epidemic in 2001
Geographical area (farm location) Geographical area, which the farm was situated in, categorised as Area A-(Gloucestershire, Herefordshire/
Worcestershire), Area B-
(northeast Devon, south Somerset), Area C-(northwest Devon, northeast Cornwall)
Cattle age (years) In yearly intervals from 2 years old up to 10 years and over
Herd size Taken from the VetNet database the average number of cattle present in the herd during the study period
Birthplace of replacement cattle Cattle were homebred (tested in natal herd) or purchased (tested in herd different from natal herd)
Dairy cattle Yes or no dairy cattle were present in the herd
Grower cattle Yes or no grower cattle were present in the herd
Season Time when visit took place. Winter (December, January and February), Spring (March, April and May), 
Summer (June, July and August) and Autumn (September, October and November)BMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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repeated measure at each visit (level 1), clustered by cow
(level 2), and herd (level 3) to control for the dependency
between repeated measures within cattle and cattle within
herds. The multivariable models were built using both
manual forward selection and backwards elimination.
The models took the form:
Yijk = βX0 + βXk + βXjk + βXijk + νk + ujk + eijk (1)
where Yijk is the PP value or seropositivity value at visit i
from cow j in herd k. βX0 is the intercept, βX is a series of
vectors of fixed effect varying at the herd (k), cattle (jk)
and visit (ijk), νk + ujk are the variances at the herd and cat-
tle levels, and eijk is the residual variance.
The model fit was assessed by plotting the raw, standard-
ised and deletion residuals, and the leverage and influence
for each random effect and all fixed effects were also
assessed [21]. The detection of outliers in the models was
completed using a top-down approach [22]: outliers at
level 3 (herds) were examined first, and then the lower
level clusters (cattle and visits). A model which included
only the seropositive herds in Dataset B was also built
using the procedure above.
Correlations between the explanatory variables were
investigated using chi-squared tests. Variables that were
significantly (P < 0.01) associated with each other were
noted to help with interpretation. All analyses were done
using MLwiN version 2.02 (Centre for Multilevel Model-




All 107 unvaccinated herds were visited at least once, 96
were visited twice and 95 were visited on three occasions,
generating 9136, 8099 and 7850 serum samples, respec-
tively. A further 1833 blood samples were collected from
additional visits or because of a whole herd test and/or
cattle were under 2 years of age.
Vaccination and clinical signs
The median herd size of vaccinated herds was 274; in con-
trast, the median herd size of unvaccinated herds was 185.
The median herd size of unvaccinated seronegative and
seropositive herds was 58 and 193, respectively. Nine per-
cent (10/114) of farmers reported that they had seen clin-
ical signs of IBR in their herd in the past, and two of these
farmers also reported that they now vaccinated their cat-
tle. All vaccinated herds had at least one seropositive ani-
mal compared with 83.2% of unvaccinated herds with at
least one seropositive animal. The mean within-herd sero-
prevalence in vaccinated herds was 74.9% compared with
43.2% in unvaccinated herds.
Herd and cattle BHV-1 seroprevalence
There were 89 herds (83.2%, 95% CI, 77.6% – 88.8%)
with at least one BHV-1 seropositive bovine on at least
one occasion (Table 2). A total of 6,993 cattle (49.0%,
95% CI, 48.2% – 49.8%) always tested negative, and
6,056 always tested positive (42.5%, 95% CI, 41.7% –
43.3%) (Table 2). Nine hundred and eighty five cattle
from 53 herds seroconverted between one test and the
next, indicating transmission of virus within these herds.
The mean and median herd BHV-1 seroprevalence were
43.2% and 40.0% (range, 0.9% – 99.2%) (Table 2). When
only the herds where seroconversion had occurred were
analysed, the mean and median within herd seropreva-
lence were 52.9% and 57.1% (range, 2.1% – 99.2%)
(Table 2). There was a large statistically significant differ-
ence between the median seroprevalence in herds where
cattle had seroconverted (57.1%) and those where they
had not (10.6%): U = 1908; P <0.05, (Mann-Whitney U-
test).
Table 2: Number and percentage of seropositive BHV-1 herds and cattle by visit type for Dataset A (26,918 samples, 14,243 cattle, 107 
herds), and herd BHV-1 antibody seroprevalence for positive herds only.
Visit Positive herds Positive cattle Herd seroprevalence for positive herds
Number % Number % Median Mean Prevalence range
1st routine visit 85 79.4 4,228 46.3 40.0 (51.7) 42.8 (50.9) 0.9 – 95.9
(2.1 – 95.9)
2nd routine visit 74 77.1 3,918 48.4 45.9 (60.2) 43.1 (52.7) 2.7 – 95.9
(2.9 – 95.9)
3rd routine visit/3rd routine and whole herd visit 74 77.9 4,495 50.0 40.4 (59.9) 43.6 (55.1) 2.4 – 99.2
(2.4 – 99.2)
Other non-routine visits 5 38.5 342 49.2 86.6 (73.2) 77.8 (73.4) 43.8 – 100.0
(43.8 – 100.0)
Combined 89 83.0 7,250 51.0 74.0 (74.0) 74.0 (74.0) 73.1 – 75.0
(73.1 – 75.0)
The results for herds where cattle seroconverted are in brackets.BMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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Given the reported sensitivity and specificity of the ELISA,
approximately 700 and 2,046 cattle tests during the study
are expected to be false negatives and false positives,
respectively. There were 124 cattle that tested positive and
then negative at subsequent visits. In addition, 85 cattle
changed serological status twice: 25 cattle tested positive,
negative then positive and 60 cattle tested negative, posi-
tive then negative. Note that we assume that antibody
positivity remains for life after infection; if antibody titre
wanes with time since infection, then a conversion from
positive to negative might reflect a true status rather than
a test failure.
Univariate associations with BHV-1 antibody seroprevalence
The seroprevalence of antibodies against BHV-1 increased
with age (Figure 1). The seroprevalence was consistently
higher in adult cattle in herds where there was seroconver-
sion but the same trend with age was present in seroposi-
tive herds where no cattle seroconverted (Figure 1). The
decline in antibody from 6 months of age and seroconver-
sion at approximately 13 months of age is indicative of
loss of maternal immunity followed by active seroconver-
sion (Figure 1). The seroprevalence of antibodies was
higher in large herds where cattle seroconverted compared
with large herds where no cattle seroconverted. There was
also a trend that seroprevalence was higher as herd size
increased in herds where cattle seroconverted; this was not
apparent where there was no seroconversion (Figure 2).
There was a statistically significant difference between the
medians of the two groups in Figure 2 (U = 0; P < 0.05,
Mann-Whitney U-test).
Of the 3,452 cattle with no data on their place of birth,
2,101 (60.9%) were seropositive. Of the 10,791 cattle
Unadjusted age-specific profile of the mean BHV-1 antibody seroprevalence and 95% CI by quarter year (up to 2 years of old)  and year (after 2 years old) for seropositive herds Figure 1
Unadjusted age-specific profile of the mean BHV-1 antibody seroprevalence and 95% CI by quarter year (up to 
2 years old) and year (after 2 years old) for seropositive herds. Herds are dichotomised by presence of seroconver-
sion in the period of study. All cattle greater than 10 years of age were categorised in one age group. Data came from all visits 
to BHV-1 unvaccinated herds (Dataset A, see methods section).
 BMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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with data, purchased cattle were significantly more likely
to be seropositive (54.1%) than homebred cattle (43.6%).
The mean PP value was higher for cattle purchased into
dairy herds, and increased at a greater rate over time from
purchase in cattle ≥ 2 years of age at purchase (Figure 3).
There was a highly significant departure from homogene-
ity between the four categories in Figure 3, χ2 = 12137, P
< 0.01. There was a significant association between season
of visit and PP values. Samples taken in the spring and
summer had significantly lower PP values than samples
taken in winter; whereas those taken in autumn had sig-
nificantly higher PP values than those taken in winter.
There was no significant association between restocked/
continuously stocked herds and herd seroprevalence in
the univariate analysis: 16.7% of restocked herds and
16.9% continuously stocked herds had no seropositive
cattle. The herd type with the highest seroprevalence was
dairy cattle only (Table 3). There were no herds with dairy
cattle and young stock (e.g. dairy with grower herds) that
were seronegative.
Hierarchical model results
There were 19,633 samples (level 1), from 10,039 cattle
(level 2) in 102 herds (level 3) with no missing values. In
the continuous outcome model there was a significant
increase in PP value with age. Cattle from herds with >200
cattle had higher PP values compared with those from
herds with ≤ 200 cattle, and there were higher PP values in
herds that were formed by restocking after the FMD epi-
demic of 2001, compared with herds that were continu-
ously stocked. Herds with dairy cattle had higher PP
values compared with those without dairy cattle. Herds
with grower cattle had lower PP values compared with
those without grower cattle (Table 4). In contrast to the
univariate results, probably because of the relationship
with the restocking variable, purchased cattle had a lower
PP value than homebred cattle. The samples collected in
spring and summer had significantly lower PP values than
those collected in the winter, whereas those taken in the
autumn had significantly higher PP values than those
taken in winter. There were no significant interactions.
The same fixed effects were associated with PP values in
Mean herd BHV-1 seroprevalence and 95% CI for seropositive herds by herd size (Numbers indicate the number of herds in  each category) Figure 2
Mean herd BHV-1 seroprevalence and 95% CI for seropositive herds by herd size (Numbers indicate the 
number of herds in each category). Herds are dichotomised by presence of seroconversion.
 BMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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Mean and 95% CI BHV-1 PP value by the number of years after purchase for age group at purchase and herd purpose Figure 3
Mean and 95% CI BHV-1 PP value by the number of years after purchase for age group at purchase and herd 
purpose.
 
Table 3: Descriptive statistics of the type of herd and number of BHV-1 seropositive unvaccinated herds (Dataset A, see methods 
section).
Cattle prevalence in positive herds
Herd type Mean number of cattle present in herd No. positive herds Total No. herds Mean Median Range
Suckler herd 1–100 10 18 16.8 7.2 2.5–74.1
Suckler herd >100 13 16 38.2 34.0 2.3–80.5
Dairy herd 1–100 5 6 27.4 17.3 7.8–58.7
Dairy herd >100 35 36 53.1 57.7 0.5–95.4
Suckler with grower herd 1–100 4 7 44.4 49.9 2.7–75.3
Suckler with grower herd >100 11 11 35.9 34.8 2.6–72.6
Dairy with grower herd 1–100 0 0 - - -
Dairy with grower herd >100 9 9 27.2 18.6 1.9–73.0
Four herds had missing average herd size from the interview questionnaire.BMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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seropositive herds only (data not shown). When a varia-
ble indicating that cattle on a farm had/had not serocon-
verted was included (as in Figures 1 and 2) in the final
model, all other variables became non-significant.
The sum of the level 1, level 2, and level 3 variances was
0.28. The greatest unexplained variance in PP values in the
final multi-level model was between cattle, making up
48% of the total variance. However, the variances were
significant at all three levels (Table 4).
The normal probability plots of the standardised residuals
for all three levels were linear (e.g. Figure 4), indicating
that the normality assumption was met. The deleted resid-
uals did not differ greatly from the respective standardised
residual values, indicating that there were no large outliers
in the data at any level. When the herds, cows or samples
with the largest influence were removed, the fit of the
model worsened but the results of the model remained
unchanged.
The estimated risks were similar when a multi-level binary
logistic regression model (outcome seropositive yes/no)
was fitted (Table 4). The variables that did not remain sig-
nificant were whether cattle were homebred or purchased
and whether herds had grower cattle.
Discussion
This is the largest seroepidemiological study of BHV-1 car-
ried out in cattle herds in the UK, and the first for more
Table 4: Repeated measures multi-level model of 10,039 cattle from 102 unvaccinated herds with PP BHV-1 levels as the continuous 
outcome and seropositive yes/no as the discrete outcome (Dataset B, see methods section).
Continuous Discrete outcome
Variable Category level No. herds No. cattle No. obs Coef SEb P value Coef SEb P value
Intercept -0.05 0.08 2.95 0.42
Triplet codea Reactive 35 3839 7286
Proactive 31 4900 8660 -0.17 0.09 0.05 -0.43 0.46 0.35
Survey 36 3665 7776 -0.10 0.09 0.28 -0.19 0.48 0.69
Restocked No 82 10235 19398
Yes 24 2278 4433 0.23 0.07 <0.01 1.10 0.36 <0.01
Farm location Area A 33 2736 4975
Area B 62 8644 16438 -0.01 0.09 0.91 -0.53 0.47 0.26
Area C 11 1133 2418 -0.01 0.13 0.94 -0.51 0.72 0.48
Age (years) 2 91 1901 1969
3 101 3996 4401 0.08 0.01 <0.01 0.16 0.07 0.02
4 102 3877 4325 0.24 0.01 <0.01 0.72 0.07 <0.01
5 100 3239 3634 0.35 0.01 <0.01 1.11 0.07 <0.01
6 101 2652 2870 0.41 0.01 <0.01 1.36 0.08 <0.01
7 96 2011 2181 0.48 0.01 <0.01 1.51 0.08 <0.01
8 96 1520 1658 0.53 0.02 <0.01 1.59 0.10 <0.01
9 94 1001 1118 0.59 0.03 <0.01 1.67 0.16 <0.01
>10 88 641 1675 0.50 0.08 <0.01 0.52 0.70 0.46
Herd size 3–68 22 644 1246
70–137 22 1488 2944 -0.02 0.09 0.88 -0.05 0.50 0.92
141–199 20 2118 4232 0.05 0.09 0.59 0.88 0.49 0.07
200–274 19 2921 5969 0.25 0.10 <0.01 1.53 0.52 <0.01
284–847 19 5233 9331 0.40 0.10 <0.01 2.21 0.53 <0.01
Herd had No 53 3049 6362
dairy cattle Yes 53 9482 17469 0.18 0.06 <0.01 1.02 0.33 <0.01
Herd had No 79 10092 19019
grower cattle Yes 27 2439 4812 -0.12 0.07 <0.01 -0.29 0.35 0.41
Cattle birthplace Homebred 83 5654 11059
Purchased 82 3894 7545 -0.06 0.01 0.07 -0.01 0.06 0.87
Season Winter 55 4008 6862
Spring 52 4715 8166 -0.07 0.01 <0.01 -0.25 0.06 <0.01
Summer 26 2342 3331 -0.02 0.01 0.05 -0.09 0.08 0.326
Autumn 31 2829 4095 0.10 0.01 <0.01 0.59 0.07 <0.01
aSee Table 1 for variable definition
bStandard Error
The random effects of the repeated measures multi-level model (Variance and SE) Herd: 0.07 and 0.01; Cattle: 0.14 and 0.003; Visit: 0.08 and 0.001.BMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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than 15 years. The seroprevalence of BHV-1 has increased
dramatically since the 1960s in both cattle and herds. In
the 1960s the seroprevalence in cattle was 2.1% [6], whilst
in the current study, 42.5% of cattle always tested positive.
Similarly, the herd prevalence was 20% in 1974 [24], and
83.2% in the current study. The differences in herd sero-
prevalence between the current and previous studies
could be explained in part if the herds in this study were
biased towards a particular location, age or cattle purpose
since these were factors that influenced herd seropreva-
lence (Table 4). However, the consistency of seropositivity
across the farms in this study over the 3 year time period
suggests that infection has reached a temporal equilib-
rium, or possibly that seropositivity is increasing slowly.
A particularly interesting result is the higher seropreva-
lence in herds that were restocked after FMD. Carrique-
Mas et al. (2008) [25] reported that bovine tuberculosis
could be introduced into a farm at restocking when cattle
were bought from herds with high incidence of infection.
It is highly likely that purchase will have brought BHV-1
into restocked herds. The reason for the apparent increase
in seroprevalence of BHV-1 is unknown but it might be
that movement and mixing in new herds is stressful for
cattle, resulting in recrudescence of virus in infected cattle
that then infect susceptible cattle in the newly formed
herd. In non-restocked herds, purchased cattle had a
lower seroprevalence, which is contradictory to this expla-
nation. It should also be remembered that the vaccination
status of individual cattle is unknown so that the differ-
ence in seroprevalence might be explained by differences
in purchasing vaccinated cattle, especially in dairy herds.
There may also be complex interactions between cattle
age, purchasing and restocking, since restocking of herds
Normal probability plot of the standardised residuals for the herd level in Model 1 where all unvaccinated herd were included  Table 3 Figure 4
Normal probability plot of the standardised residuals for the herd level in Model 1 where all unvaccinated herd 
were included Table 3.
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is very different to "routine" purchase. Additionally, the
existence of multiple antigenic types (which cannot be
distinguished serologically) means that interpretation of
seroepidemiology is not straightforward. Whatever the
cause, these results suggest that these purchased cattle
were associated with a high herd seroprevalence and high-
light the point that farmers should consider the antibody
BHV-1 status of cattle before introduction, to prevent con-
comitant introduction or re-introduction of BHV-1 of the
same or a different antigenic type, that might influence
disease presentation.
The seroprevalence of BHV-1 increased with herd size in
the univariate analysis and in the hierarchical model; this
is consistent with other studies [16,26-28]. The associa-
tion with herd size was greater in herds where seroconver-
sion occurred during the study (Figure 2), suggesting that
active transmission is related positively to herd size, per-
haps because larger herds have more potential transmis-
sion contacts both within the herd and with other herds
(e.g. from veterinarians, other farmers and purchased cat-
tle). However, the association between BHV-1 PP values
and herd size might be confounded with other factors
associated with herd size, e.g. recrudescence of infection
through stress [29], or exposure to more viral types.
The age serological profile is consistent with life-long
seropositivity. Antibodies to BHV-1 in calves of ≤ 6
months of age probably correspond to colostrum derived
maternal immunity. This wanes by 1 year of age, and starts
to rise by 2 years of age because of active infection. This
suggests that the optimum age for vaccination of cattle is
10 – 14 months of age, although with some active sero-
conversion observed in adult cattle and a seroprevalence
only exceeding 50% in older animals, vaccination is likely
to have a positive impact when administered at any age.
All the vaccinated herds had seropositive cattle, while
approximately 80% of the unvaccinated herds had serop-
ositive cattle. On average, less than 50% of the cattle in the
unvaccinated herds tested positive at each visit, whilst
>75% of the cattle from vaccinated herds were positive.
These data suggest that either some cattle in vaccinated
herds were not vaccinated, that vaccination does not
always induce antibody or that antibody titre induced by
vaccination wanes over time. It is possible that antibody
titre generated by natural infection also wanes over time,
but there is no previous work on this hypothesis.
In the current study, when the herd was a dairy herd rather
than a suckler herd, the rate of seroconversion in adults
was greater. The average age of cattle did not differ
between dairy and suckler herds, and so this is a true
effect, possibly due to winter housing or other stressors
related to dairy cow management.
Housing and winter stressors are also an explanation for
the small but significant effect of season on PP values.
However, 31% and 47% of visits were 11–13 months
apart for routine visits 1 and 2 and routine visits 2 and 3,
respectively, so that there was a tendency for the same
herds to be sampled in the same season and so herd effect
is interpreted as an apparent seasonal effect. Other expla-
nations are that seasonal culling and replacement of cattle
might influence herd prevalence of BHV-1 antibodies.
All the variables above became non-significant when the
binary variable seroconversion (indicating whether sero-
conversion was observed in the herd) was introduced into
the final model. This indicates that the model risk factors
are those associated with virus circulation between cattle
on the farm.
The use of different modelling approaches has been dis-
cussed elsewhere [28,30] but not modelling different dis-
tributions of the same outcome. We compared these two
outcomes because we wanted to investigate change in
antibody level that was not necessarily occurring around
the cut off. The associated risks were similar to those in
Table 4 whether the data were modelled using a continu-
ous or binary outcome, but the presence of grower cattle
and purchased or homebred were not statistically signifi-
cant in the binomial model, although the trends were in
the same direction of risk. This suggests that these varia-
bles alter the antibody titre either always above or below
the cut off and that this change was detectable in the con-
tinuous outcome model but not in the discrete model.
In the discrete model, we assumed that the serological
measurement of seropositive/seronegative had perfect
sensitivity and specificity. It is possible that bias could be
introduced into the analysis if the sensitivity or specificity
of the test varied with other variables, for example, with
cattle age, or time since infection, however this has not
been reported for BHV-1 antibody tests. The continuous
outcome (PP) calculated from the ELISA will have had
some random error (Figure 4), but avoided the need to
categorise cattle as positive or negative to BHV-1 anti-
body, and avoided the possibility of misclassification due
imperfect sensitivity and specificity, although would have
retained a bias if serological measurement varied with
other variables. However, the consistency between the dis-
crete and continuous outcome models suggests that sensi-
tivity and specificity do not alter with any of the
explanatory variables in the model.
The results of this study do not necessarily represent all
cattle herds in England, because of the locality of the
farms sampled and because the analysis was based prima-
rily on the serological values for BHV-1 from adult cattle.
Using only unvaccinated herds in the study may haveBMC Veterinary Research 2009, 5:5 http://www.biomedcentral.com/1746-6148/5/5
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reduced the extrapolation of the results, because these
herds may have had different management practices from
vaccinated herds, but there were only 7 herds that report-
edly used vaccination and so analysis of these herds' man-
agements was not possible. In addition, there might have
been an overestimation of the infection derived seroprev-
alence because purchased cattle might have been sourced
from a vaccinated herd and so had antibodies derived
from vaccination: we do not know the vaccination status
of source herds. The serological test used in the current
study did not distinguish between vaccine derived and
pathogen derived antibody so this was unavoidable. It is
interesting that only 7 herds were vaccinated and that
farmers reported little clinical disease from BHV-1, sug-
gesting that this infection is not an obvious production
constraint or clinical disorder in most herds.
Finally, in the current analysis we could not distinguish
between BHV-1 sub-types, the epidemiology of individual
types might be different and this might account for some
of the unexplained heterogeneity. BHV-1 subtype 3 is now
classified as a new species (bovine herpesvirus-5 or BHV-
5) [31]. It is probable that we were detecting antibodies to
BHV-5 as well as BHV-1 because these viruses are antigen-
ically related.
Conclusion
In conclusion, the level of BHV-1 infection has increased
dramatically since previous estimates from the UK, with
approximately 83% of the unvaccinated herds in the
south west of England seropositive. This study adds to pre-
vious work with the finding that infection might have
reached a temporal but not a spatial equilibrium and that
between herd variability in PP might arise through varia-
bility in cattle age, herd size, herd purpose and the forma-
tion of new herds.
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